TRKB | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

140 results for “TRKB”

Trials

View all 57 →

Preoperative Study of the Correlation Between BDNF-TrkB Signaling Pathway Expression Levels in Cerebrospinal Fluid and Blood and Postpartum Depression

200 participants · First posted Apr 27, 2025

Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma

40 participants · First posted Apr 23, 2014

Pharmacokinetic study of TRK-820 -Pharmacokinetic study among TRK-820 tablets and TRK-820 soft capsules.-

8 participants

Drugs

View all 67 →

TrkB agonist antibody

TrkB Agonist(Abzyme Therapeutics)

TrkB positive allosteric agonists (Addex)

Organizations

TRB CHEMEDICA

France

TRB Chemedica AG

Germany

TRB KEMEDIKA INTERNESHNL S.A., PREDSTAVITELSTVO

Russia

News

View all 12 →

Kasvu Therapeutics Raises €30M to Advance Non-Hallucinogenic TrkB-Targeting Depression Drug KTX-0141

Micot Pharma's MT200605 Hits Phase II Primary Endpoint in Acute Ischemic Stroke, Offering First-in-Class Multi-Stage Neuroprotection

NexTel Medical to Acquire Xycota Biosciences, Gaining Exosome-Delivered Neuro-Restoration Platform with Pending FDA Orphan Drug Designation

Page 1 of 14